Neo-Mercazole (Carbimazole)

Carbimazole, the active ingredient in Neo-Mercazole, is an antithyroid agent presented as an oral formulation for oral use. It is employed to manage hyperthyroidism by reducing excess thyroid hormone production in adults and children with conditions such as Graves disease and toxic multinodular goiter.

GNH USA supplies Neo-Mercazole as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑compliant shipments to global markets, following Good Manufacturing Practice to ensure consistent potency and safety for patients.

Carbimazole is used to treat hyperthyroid conditions by inhibiting thyroid hormone synthesis.

- Graves disease: reduces excess thyroid hormone production, helping control symptoms and biochemical abnormalities. - Toxic multinodular goiter: decreases hormone output from autonomous nodules, stabilizing thyroid function. - Other forms of hyperthyroidism: lowers circulating T3 and T4 levels in less common hyperthyroid disorders.

Carbimazole may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea or upset stomach - Skin rash or itching - Taste disturbance or loss of taste - Arthralgia or muscle aches - Mild elevation of liver enzymes

Serious or Rare Side Effects: - Agranulocytosis (dangerously low white blood cell count) - Severe liver injury or hepatitis - Vasculitis, including cutaneous or systemic forms - Aplastic anemia or bone‑marrow suppression - Thyroid storm precipitated by rapid hormone changes

When prescribing carbimazole, clinicians should observe several safety measures to minimize risks.

- Thyroid function monitoring: check TSH, free T4 and T3 regularly to adjust dose. - Dose titration: start with the lowest effective dose and increase gradually. - Bone‑marrow suppression: avoid in patients with existing neutropenia or severe infection. - Elderly patients: use lower initial doses and monitor closely for adverse effects. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Carbimazole can affect, or be affected by, several concomitant medicines.

Major Interactions (Avoid): - Lithium: combined use may increase risk of hypothyroidism and requires close monitoring. - Warfarin: carbimazole can potentiate anticoagulant effect, raising INR and bleeding risk. - Interferon‑alpha or other immune‑modulating agents: may exacerbate thyroid dysfunction.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of thyrotoxicosis; dose adjustments may be needed. - Digoxin: altered thyroid status can change digoxin levels; monitor serum concentrations. - Theophylline: carbimazole may reduce clearance, increasing theophylline toxicity risk.